Prelude Capital Management, LLC Bruker Corp Transaction History

Prelude Capital Management, LLC

$1.85 Billion
Q1 2024

A detailed history of Prelude Capital Management, LLC transactions in Bruker Corp stock. As of the latest transaction made, Prelude Capital Management, LLC holds 3,665 shares of BRKR stock, worth $225,947. This represents 0.02% of its overall portfolio holdings.

Number of Shares

3,665

Previous 2,801 30.85%

Holding current value

$225,947

Previous $205,000 67.8%

% of portfolio

0.02%

Previous 0.01%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$69.21 - $94.27 $59,797 - $81,449	864 Added 30.85%	3,665 $344,000
Q4 2023 Feb 14, 2024	BUY	$54.91 - $74.64 $153,802 - $209,066	2,801 New	2,801 $205,000
Q4 2022 Feb 14, 2023	BUY	$54.36 - $69.91 $181,508 - $233,429	3,339 New	3,339 $228,000
Q1 2022 May 16, 2022	SELL	$61.72 - $80.99 $148,128 - $194,376	-2,400 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$74.85 - $85.37 $179,640 - $204,888	2,400 New	2,400 $201,000

Q4 2020 Feb 16, 2021	SELL	$38.78 - $55.48 $28,658 - $40,999	-739 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$38.34 - $46.17 $28,333 - $34,119	739 New	739 $29,000
Q1 2020 May 15, 2020	SELL	$31.86 - $53.99 $58,017 - $98,315	-1,821 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$42.36 - $51.75 $77,137 - $94,236	1,821 New	1,821 $93,000
Q2 2019 Aug 14, 2019	SELL	$37.48 - $49.95 $9,632 - $12,837	-257 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$26.45 - $34.9 $5,290 - $6,980	-200 Reduced 43.76%	257 $8,000
Q3 2018 Nov 14, 2018	BUY	$28.41 - $35.62 $5,142 - $6,447	181 Added 65.58%	457 $15,000
Q2 2018 Aug 14, 2018	SELL	$29.04 - $32.33 $21,024 - $23,406	-724 Reduced 72.4%	276 $8,000
Q1 2018 May 15, 2018	BUY	$29.12 - $36.23 $29,120 - $36,230	1,000 New	1,000 $30,000

Others Institutions Holding BRKR

# of Institutions

402

Shares Held

100M

Call Options Held

211K

Put Options Held

14.5K

View Full List

About BRUKER CORP

Ticker BRKR
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 148,138,000
Market Cap $9.13B
Description
Bruker Corporation develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States and internationally. The company operates through three segments: Bruker Scientific Instruments (BSI) Life Science, BSI NANO, and Bruker Energy & Supercon Technologies. It offers life science tools, ...

More about BRKR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prelude Capital Management, LLC with notifications on news.

Account

Prelude Capital Management, LLC Bruker Corp Transaction History